AI is driving first-principles rethinking of compute architectures, driven by enormous demand and completely new (and massive) workloads.
It's exciting when bio / science moves at AI speed – see @glebkuz & @ManifoldBio's note on their new mBER-2 protein design model enabling microbinders (compact protein formats from nature) and drug development components. Now already integrated in the Anthropic × Adaptyv protein design competition!
An FDA advisory committee reviews GRAIL's Galleri Test multi-cancer early detection (MCED) test this...
An FDA advisory committee reviews GRAIL's @GalleriTest multi-cancer early detection (MCED) test this Wednesday. The WSJ editorial board laid out the record this weekend. Lines worth reading:
AI inference needs massive memory bandwidth and rack-scale plumbing. d-Matrix & NVIDIA partnership a...